Corticosteroid-use in primary and secondary brain tumour patients: a review

被引：38
|
作者：
Ryan, Richella [1 ]
Booth, Sara [1 ,2 ,3 ]
Price, Stephen [2 ,4 ]
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Palliat Care Dept, Cambridge CB2 0QQ, England
[2] Univ Cambridge, Cambridge, England
[3] Kings Coll London, London WC2R 2LS, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 0QQ, England
来源：
JOURNAL OF NEURO-ONCOLOGY | 2012年 / 106卷 / 03期
关键词：
Brain neoplasms; Corticosteroids; Quality of life; GLUCOCORTICOID-RECEPTOR GENE; ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; DEXAMETHASONE TREATMENT; CAPILLARY-PERMEABILITY; VASCULAR-PERMEABILITY; INDUCED OSTEOPOROSIS; PHASE-II; EDEMA; EXPRESSION;
D O I：
10.1007/s11060-011-0713-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Corticosteroids have been effective in the management of cerebral oedema, in the context of brain tumours, for many decades. Though their effectiveness is well-established, this needs to be balanced against their potential to cause significant side effects. There is currently little consensus in the literature about how this should be done. This article reviews the literature, specifically in relation to the role of corticosteroids in primary and secondary brain tumour patients. Areas reviewed include corticosteroid pharmacology, indications, mechanism of action, toxicity profile, prescribing practices, and corticosteroid-sparing agents.
引用
收藏
页码：449 / 459
页数：11
相关论文
共 50 条
  • [31] Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma
    Campos, S.
    Davey, P.
    Hird, A.
    Pressnail, B.
    Bilbao, J.
    Aviv, R. I.
    Symons, S.
    Pirouzmand, F.
    Sinclair, E.
    Culleton, S.
    DeSa, E.
    Goh, P.
    Chow, E.
    CURRENT ONCOLOGY, 2009, 16 (01) : 62 - 66
  • [32] UNMET NEEDS AND WISH FOR SUPPORT OF INFORMAL CAREGIVERS OF PRIMARY BRAIN TUMOUR PATIENTS
    Pointon, L.
    Grant, R.
    Peoples, S.
    Erridge, S.
    Sherwood, P.
    Klein, M.
    Boele, F.
    NEURO-ONCOLOGY, 2021, 23 : 31 - 32
  • [33] A study of patients with a primary malignant brain tumour and their carers: symptoms and access to services
    Arber, Anne
    Faithfull, Sara
    Plaskota, Marek
    Lucas, Caroline
    de Vries, Kay
    INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2010, 16 (01) : 24 - 30
  • [34] UNMET NEEDS AND WISH FOR SUPPORT OF FAMILY CAREGIVERS OF PRIMARY BRAIN TUMOUR PATIENTS
    Pointon, Lucy
    Grant, Robin
    Peoples, Sharon
    Erridge, Sara
    Sherwood, Paula
    Klein, Martin
    Boele, Florien
    NEURO-ONCOLOGY, 2021, 23 : 162 - 162
  • [35] ERYTHRODERMIC PSORIASIS SECONDARY TO SYSTEMIC CORTICOSTEROID USE AND CESSATION
    Heinrich, M.
    Medrano, R. M.
    Payne, D.
    Bijlani, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 577 - 577
  • [36] Clinical review: A systematic review of corticosteroid use in infections
    Jody Aberdein
    Mervyn Singer
    Critical Care, 10
  • [37] Clinical review: A systematic review of corticosteroid use in infections
    Aberdein, Jody
    Singer, Mervyn
    CRITICAL CARE, 2006, 10 (01)
  • [38] Use of calcimimetics in uremic patients with secondary hyperparathyroidism:: Review
    Ureña, P
    ARTIFICIAL ORGANS, 2003, 27 (09) : 759 - 764
  • [39] Healthcare use and costs of primary and secondary care patients with prostatitis
    Turner, JA
    Ciol, MA
    Von Korff, M
    Rothman, I
    Berger, RE
    UROLOGY, 2004, 63 (06) : 1031 - 1035
  • [40] Papilloedema in Patients With Brain Tumour
    Serova, N.
    Eliseeva, N.
    Shifrin, M.
    NEURO-OPHTHALMOLOGY, 2009, 33 (03) : 100 - 105
12345